Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Counseling | 8 | 2021 | 380 | 1.930 |
Why?
|
| Neoplastic Syndromes, Hereditary | 5 | 2022 | 221 | 1.180 |
Why?
|
| Disclosure | 2 | 2018 | 181 | 1.060 |
Why?
|
| Counselors | 2 | 2021 | 18 | 0.820 |
Why?
|
| Oncologists | 2 | 2023 | 134 | 0.760 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 469 | 0.630 |
Why?
|
| Exome | 3 | 2022 | 1239 | 0.620 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 338 | 0.590 |
Why?
|
| Interviews as Topic | 2 | 2018 | 497 | 0.590 |
Why?
|
| Genetic Testing | 10 | 2023 | 1589 | 0.590 |
Why?
|
| Peutz-Jeghers Syndrome | 2 | 2017 | 56 | 0.580 |
Why?
|
| Haploinsufficiency | 2 | 2017 | 294 | 0.520 |
Why?
|
| Genomics | 8 | 2023 | 2738 | 0.510 |
Why?
|
| Research Subjects | 1 | 2015 | 65 | 0.490 |
Why?
|
| Genetic Research | 1 | 2015 | 63 | 0.490 |
Why?
|
| Parents | 2 | 2018 | 998 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2022 | 5539 | 0.480 |
Why?
|
| Death | 1 | 2015 | 119 | 0.470 |
Why?
|
| Health Personnel | 2 | 2018 | 625 | 0.450 |
Why?
|
| Communication | 2 | 2018 | 876 | 0.440 |
Why?
|
| Li-Fraumeni Syndrome | 3 | 2022 | 158 | 0.440 |
Why?
|
| Professional-Family Relations | 3 | 2018 | 134 | 0.410 |
Why?
|
| Intestinal Polyposis | 2 | 2022 | 30 | 0.400 |
Why?
|
| Genome, Human | 5 | 2022 | 1869 | 0.380 |
Why?
|
| Germ-Line Mutation | 6 | 2022 | 1046 | 0.370 |
Why?
|
| Informed Consent | 3 | 2019 | 419 | 0.340 |
Why?
|
| Neoplasms | 5 | 2023 | 15193 | 0.250 |
Why?
|
| Phenotype | 4 | 2019 | 6295 | 0.250 |
Why?
|
| Child | 14 | 2022 | 29154 | 0.250 |
Why?
|
| Decision Making | 5 | 2023 | 1287 | 0.240 |
Why?
|
| Information Seeking Behavior | 1 | 2023 | 34 | 0.230 |
Why?
|
| DNA Mismatch Repair | 2 | 2022 | 268 | 0.220 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 19 | 0.210 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 178 | 0.210 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 206 | 0.210 |
Why?
|
| Multilingualism | 2 | 2018 | 31 | 0.200 |
Why?
|
| MyoD Protein | 1 | 2021 | 36 | 0.200 |
Why?
|
| Ribonuclease III | 1 | 2022 | 182 | 0.190 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 74 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 255 | 0.180 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 59 | 0.180 |
Why?
|
| Smad4 Protein | 1 | 2020 | 196 | 0.170 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 109 | 0.170 |
Why?
|
| Medical Oncology | 2 | 2018 | 1423 | 0.170 |
Why?
|
| Humans | 30 | 2023 | 261506 | 0.170 |
Why?
|
| Colectomy | 1 | 2020 | 288 | 0.160 |
Why?
|
| Watchful Waiting | 1 | 2020 | 289 | 0.160 |
Why?
|
| Cultural Competency | 1 | 2018 | 60 | 0.160 |
Why?
|
| Allied Health Personnel | 1 | 2018 | 73 | 0.160 |
Why?
|
| Counseling | 1 | 2020 | 381 | 0.160 |
Why?
|
| Rhabdomyosarcoma | 1 | 2021 | 341 | 0.160 |
Why?
|
| Empathy | 1 | 2018 | 101 | 0.150 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2017 | 61 | 0.150 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2017 | 37 | 0.150 |
Why?
|
| Pinealoma | 1 | 2017 | 49 | 0.150 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 119 | 0.150 |
Why?
|
| Precision Medicine | 2 | 2021 | 1154 | 0.140 |
Why?
|
| Language | 1 | 2018 | 309 | 0.140 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2022 | 600 | 0.140 |
Why?
|
| Language Development Disorders | 1 | 2017 | 167 | 0.140 |
Why?
|
| Patients | 1 | 2018 | 245 | 0.140 |
Why?
|
| Child, Preschool | 6 | 2020 | 16273 | 0.140 |
Why?
|
| Truth Disclosure | 1 | 2017 | 180 | 0.140 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 792 | 0.140 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2017 | 221 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 239 | 0.130 |
Why?
|
| Retinoblastoma | 1 | 2017 | 200 | 0.130 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 3578 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2017 | 414 | 0.130 |
Why?
|
| Professional Role | 1 | 2015 | 78 | 0.120 |
Why?
|
| Microcephaly | 1 | 2017 | 325 | 0.120 |
Why?
|
| Medulloblastoma | 1 | 2019 | 540 | 0.120 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 882 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2022 | 4849 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 2403 | 0.120 |
Why?
|
| Adolescent | 7 | 2023 | 31252 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 573 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3821 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 143 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 854 | 0.100 |
Why?
|
| Polyps | 1 | 2012 | 74 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 4821 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2017 | 686 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 1020 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2017 | 899 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 1498 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 998 | 0.100 |
Why?
|
| Adult | 7 | 2020 | 77950 | 0.100 |
Why?
|
| Physicians | 1 | 2018 | 882 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2022 | 3552 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1491 | 0.090 |
Why?
|
| Stomach | 1 | 2012 | 387 | 0.090 |
Why?
|
| Germ Cells | 2 | 2022 | 335 | 0.080 |
Why?
|
| Young Adult | 4 | 2023 | 21445 | 0.080 |
Why?
|
| Translating | 2 | 2018 | 45 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1005 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 2483 | 0.080 |
Why?
|
| Female | 11 | 2022 | 141928 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2017 | 5270 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4638 | 0.070 |
Why?
|
| Infant | 2 | 2017 | 13310 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2017 | 2979 | 0.060 |
Why?
|
| Population Groups | 1 | 2023 | 42 | 0.060 |
Why?
|
| Uncertainty | 1 | 2023 | 320 | 0.050 |
Why?
|
| Male | 7 | 2021 | 123000 | 0.050 |
Why?
|
| Accreditation | 1 | 2020 | 126 | 0.050 |
Why?
|
| Mutation | 4 | 2022 | 15179 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2020 | 173 | 0.050 |
Why?
|
| Linguistics | 1 | 2018 | 25 | 0.040 |
Why?
|
| Family | 1 | 2023 | 736 | 0.040 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2018 | 17 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2022 | 1471 | 0.040 |
Why?
|
| Patient Participation | 1 | 2023 | 446 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2018 | 52 | 0.040 |
Why?
|
| Quinolines | 1 | 2021 | 383 | 0.040 |
Why?
|
| Pediatrics | 2 | 2017 | 1141 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2017 | 6915 | 0.040 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 649 | 0.040 |
Why?
|
| Larva | 1 | 2017 | 274 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2020 | 518 | 0.040 |
Why?
|
| Base Sequence | 1 | 2022 | 4917 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2019 | 442 | 0.030 |
Why?
|
| Imidazoles | 1 | 2021 | 999 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 287 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 216 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 434 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 463 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 945 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 323 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2017 | 403 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 2283 | 0.030 |
Why?
|
| United States | 2 | 2022 | 15433 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 661 | 0.030 |
Why?
|
| Perception | 1 | 2015 | 350 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 556 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 1143 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 860 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 5377 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 2291 | 0.020 |
Why?
|
| Health Behavior | 1 | 2014 | 603 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 1258 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5637 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2287 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 6311 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 14889 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 9244 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 7226 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 6869 | 0.020 |
Why?
|
| Animals | 2 | 2021 | 59536 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 34495 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 6550 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14289 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 70117 | 0.010 |
Why?
|